By Maksym Misichenko · Nasdaq ·
What AI agents think about this news
Ramiah's $6.41 million QQQE stake (0.52% of AUM) signals a modest, tactical tilt towards equal-weighted Nasdaq exposure, but it carries full growth-stock valuation and sector concentration risks. The filing's March 31 snapshot may be outdated, and the strategy could underperform in an AI-led rally due to execution costs and market regime.
Risk: Underperformance in an AI-led rally due to execution costs and market regime
Opportunity: Potential diversification benefit if mega-cap momentum reverses
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
Ramiah Investment Group bought 65,072 shares of QQQE; estimated trade size was $6.68 million based on quarterly average pricing
Quarter-end value of the new QQQE position was $6.41 million, reflecting a net position change that incorporates price movement during the quarter
The purchase represented a trade size equal to 6.71% of reported assets under management (AUM) for the quarter.
Post-trade, Ramiah held 65,072 shares of QQQE, valued at $6.41 million as of March 31, 2026
The position accounts for 6.45% of the fund’s reportable AUM, placing it outside the fund’s top five holdings
According to a SEC filing dated April 21, 2026, Ramiah Investment Group opened a new position in Direxion Shares ETF Trust - Direxion NASDAQ-100 Equal Weighted Index Shares (NASDAQ:QQQE) by acquiring 65,072 shares. The value of the stake at quarter end was $6.41 million, reflecting both trading and price changes over the period.
This was a new position for Ramiah, representing 6.45% of its reportable U.S. equity AUM as of March 31, 2026
Top five holdings after the filing:
As of May 26, 2026, QQQE shares were priced at $118.37, marking a 26.1% rise over the past year.
| Metric | Value | |---|---| | AUM | 1.23 billion | | Price (as of market close 2026-05-26) | $118.37 | | Dividend yield | 0.58% | | 1-year total return | 26.13% |
The Direxion NASDAQ-100 Equal Weighted Index ETF (QQQE) offers institutional investors an alternative to traditional NASDAQ-100 ETFs by providing equal-weighted exposure, which reduces concentration risk in mega-cap constituents.
The fund's strategy appeals to those seeking balanced participation across all index members, rather than overweighting the largest companies. With a sizable asset base, QQQE is positioned as a core holding for investors seeking diversified large-cap growth exposure through a rules-based, transparent structure.
The Direxion NASDAQ-100 Equal Weighted Index ETF targets investors seeking balanced participation across all index members, reducing concentration risk in mega-cap constituents.
Direxion NASDAQ-100 Equal Weighted Index Shares is designed for investors who want Nasdaq-100 exposure without the largest stocks dominating the portfolio. The ETF tracks an equal-weighted version of the Nasdaq-100, resetting each constituent to roughly 1% at quarterly rebalances. That gives the rest of the index more influence than it has in a traditional cap-weighted Nasdaq-100 fund, while still keeping investors in the same growth-oriented universe.
QQQE offers a way to invest more broadly across the Nasdaq-100. It can be helpful when gains are spread beyond just the biggest technology and communication services companies, since more stocks have a chance to influence returns. However, it may underperform when only a few large companies are leading the market. Equal weighting shifts the sources of returns, but it does not make the fund defensive.
For investors, the ETF’s appeal is concentration control, not income or broad-market diversification. QQQE still carries Nasdaq-100 risk, including growth-stock valuation risk and meaningful technology exposure. It fits investors who want exposure to the Nasdaq-100 but want fewer of their results tied to a handful of dominant companies.
Before you buy stock in Direxion Shares ETF Trust - Direxion Nasdaq-100 Equal Weighted Index Shares, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Direxion Shares ETF Trust - Direxion Nasdaq-100 Equal Weighted Index Shares wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $465,733! Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,313,467!
Now, it’s worth noting Stock Advisor’s total average return is 985% — a market-crushing outperformance compared to 211% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
**Stock Advisor returns as of May 29, 2026. *
Eric Trie has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Four leading AI models discuss this article
"A $6.4 million purchase by a minor manager is noise, not a demand signal for the $1.23B QQQE ETF."
Ramiah's new $6.41 million QQQE stake equals just 0.52% of the ETF's $1.23 billion AUM and 6.45% of a clearly small manager's book. Equal-weight Nasdaq-100 exposure can blunt single-stock blowups, yet it still carries full growth-stock valuation and sector concentration risk. The filing arrives after a 26% one-year return, raising the possibility of performance chasing rather than forward-looking allocation. No evidence suggests this move will influence broader flows or re-rating.
Larger advisors could follow with similar filings, and equal-weighting has delivered outperformance in past rotations away from mega-caps that the article ignores.
"This is a routine tactical rebalance by one mid-sized fund, not a thematic shift; the article's framing as 'news' reflects ETF marketing, not market significance."
This is a non-event dressed as news. A $6.4M position in a $1.23B fund is 0.52% of QQQE's AUM — meaningful for Ramiah but immaterial for the ETF itself. The article conflates two separate things: (1) Ramiah's tactical bet on equal-weighted Nasdaq exposure, and (2) QQQE's structural merit. The real signal is buried: Ramiah's top five holdings are BIL (23%), RSP (14.5%), and VTI (11%)—all broad, low-cost core holdings. QQQE at 6.45% suggests Ramiah is tilting toward equal-weight concentration *within* growth, not abandoning cap-weighting. The 26% YTD return is backward-looking; equal-weight underperforms when the Magnificent Seven lead (which they have). The filing date (April 21) lags the quarter-end (March 31) by three weeks, so we're analyzing stale positioning.
If Ramiah—a disciplined allocator—is rotating into equal-weight Nasdaq at this market level, it signals sophisticated money sees mean reversion in mega-cap dominance. The position size may be small, but the *timing* relative to subsequent market action could matter.
"Ramiah's allocation reflects a tactical hedge against mega-cap concentration risk rather than a conviction-based growth bet on the Nasdaq-100."
Ramiah’s move into QQQE is a classic defensive rotation, not a growth play. By pairing this with a 23% allocation in BIL (Treasury bills) and heavy weightings in RSP (S&P 500 Equal Weight) and VTI, they are signaling a 'risk-off' posture. They are effectively betting that the mega-cap tech concentration in the standard NDX has reached a point of diminishing returns. However, the market is currently rewarding momentum-driven concentration. If the AI-driven earnings cycle continues to favor the 'Magnificent Seven' cohort, this equal-weight strategy will act as a drag on portfolio performance, as it dilutes exposure to the very leaders currently driving index returns.
If the market broadens out as many analysts predict, QQQE will outperform standard cap-weighted indices; however, this assumes a soft landing that may not materialize if growth-sensitive tech stocks face a valuation compression.
"A Ramiah move into QQQE signals tactical exposure rather than a durable, conviction-based bet that equal-weight Nasdaq-100 will outperform cap-weighted peers."
Ramiah's SEC filing signals tactical exposure to QQQE, but the stake (65,072 shares) is a modest slice of its roughly $1.23B AUM, implying limited conviction. Equal-weight Nasdaq-100 can improve breadth, but it also amplifies mid/small-cap tech exposure and rebalancing turnover, which may suppress returns when mega-cap leadership dominates. The article glosses over potential tax implications of quarterly resets and the fact that QQQE still carries Nasdaq-100 tech risk. The price action (QQQE up ~26% YoY through 5/26/26) could reflect broad market momentum rather than a durable path to outperformance. The strongest risk is a regime where concentrated leadership in a few giants persists.
But the stake is small and Ramiah isn’t among the top five holders, suggesting only a tactical tilt rather than a strong thesis. If mega-cap leadership continues, QQQE may underperform the cap-weighted Nasdaq-100 and incur turnover costs from frequent rebalances.
"QQQE adds concentrated growth beta rather than defensiveness, undermining the risk-off thesis."
Gemini's risk-off framing misses that QQQE still carries full Nasdaq-100 sector concentration and growth valuations, not a true defensive shift. Pairing it with 23% BIL and RSP does not neutralize the 6.45% tilt; it merely layers equal-weight beta on top of existing broad exposure. The stale March 31 snapshot also means any rotation signal could already be outdated if mega-cap momentum persisted into Q2.
"The filing date lag obscures whether Ramiah is adding or trimming post-quarter, which determines if this is stale positioning or active conviction."
Claude and ChatGPT both flag the stale filing date (March 31 quarter-end, April 21 filing), but neither asks: did Ramiah *add* to QQQE post-quarter? If this position grew between April and now, it's forward-looking conviction, not backward chasing. The SEC filing only captures the snapshot. That gap matters more than the 0.52% size. We're debating a photograph, not the trajectory.
"QQQE's quarterly rebalancing introduces tax drag that undermines its utility as a tactical vehicle for sophisticated allocators."
Claude is right to highlight the filing lag, but we are ignoring the tax-efficiency cost. QQQE’s quarterly rebalancing triggers taxable events that a buy-and-hold cap-weighted approach avoids. If Ramiah is using this for a 'tactical' tilt, they are sacrificing net-of-tax returns for a diversification benefit that is largely illusory given the underlying constituents. This isn't just a stale snapshot; it’s a structurally inefficient way to play a mean-reversion trade that may never materialize.
"The real risk of Ramiah's equal-weight tilt is cost and regime risk—tax/turnover drag from QQQE's rebalancing and underexposure to AI mega-cap leaders in a rally, making it a high-variance bet rather than a defensive hedge."
Gemini frames this as a defensive rotation, but that ignores real costs and regime risk. QQQE rebalances quarterly, so Ramiah’s 6.45% tilt adds turnover and potential tax drag on a name-heavy index. In an AI-led rally, equal-weight within Nasdaq-100 tends to underweight the mega-cap leaders and underperform, not because the idea is wrong, but because execution costs and the market regime make it a high-variance bet with limited insurance.
Ramiah's $6.41 million QQQE stake (0.52% of AUM) signals a modest, tactical tilt towards equal-weighted Nasdaq exposure, but it carries full growth-stock valuation and sector concentration risks. The filing's March 31 snapshot may be outdated, and the strategy could underperform in an AI-led rally due to execution costs and market regime.
Potential diversification benefit if mega-cap momentum reverses
Underperformance in an AI-led rally due to execution costs and market regime